SCHEMBL529119

SCHEMBL529119

O=c1[nH]c(=O)ss1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7695026 0.55
SCHEMBL30107638 0.53
Ammonia Solution, Strong SCHEMBL2927963 0.50 IDH1 (0.41)
SCHEMBL7630570 0.50 IDH1 (0.41)
SCHEMBL1306657 0.50 IDH1 (0.41)
SCHEMBL11174049 0.50 IDH1 (0.41)
SCHEMBL15992544 0.50 IDH1 (0.41)
Hydrochloric Acid SCHEMBL237155 0.50 IDH1 (0.41)
SCHEMBL16011254 0.50 IDH1 (0.41)
SCHEMBL21647160 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 373 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7910745-B2 Organic compound and method for producing radioactive halogen-labeled organic compound using the same NIHON MEDI-PHYSICS CO., LTD. (JP) 2011-03-22 US claimed
EP-1663915-B1 METHOD FOR THE PRODUCTION OF [18F] FLUORIDE-MARKED AROMATIC L-AMINO ACIDS UNIV EBERHARD KARLS (DE) 2009-12-02 EP claimed
US-20060241318-A1 Preparation of [18F]fluorine labeled aromatic L-amino acids EBERHARD-KARLS-UNIVERSITAET TUEBINGEN UNIVERSITAETSKLINIKUM (DE) 2006-10-26 US claimed
US-6809195-B1 COMPRISES A MODIFIED PHOSPHORAMIDITE PROTOCOL IN WHICH OXIDATION AND CAPPING STEPS ARE COMBINED INTO A SINGLE STEP; INCREASED EFFICIENCY; SOLID PHASE SYNTHESIS ISIS PHARMACEUTICALS, INC. 2004-10-26 US claimed
US-20040198972-A1 Processes for the preparation of oligonucleotides ISIS PHARMACEUTICALS, INC. 2004-10-07 US claimed
EP-0948512-B1 METHOD OF SYNTHESIZING PHOSPHOROTHIOATE OLIGONUCLEOTIDES ISIS PHARMACEUTICALS INC (US) 2004-10-06 EP claimed
EP-1311526-A1 PROCESSES FOR THE PREPARATION OF OLIGONUCLEOTIDES ISIS PHARMACEUTICALS, INC. (US) 2003-05-21 EP claimed
WO-2002014340-A1 PROCESSES FOR THE PREPARATION OF OLIGONUCLEOTIDES_______________ ISIS PHARMACEUTICALS, INC. (US) 2002-02-21 WO claimed
JP-58046080-A None JP disclosed
JP-58043966-A None JP disclosed
JP-57108085-A None JP disclosed
JP-5139902-A None JP disclosed
JP-58062182-A None JP disclosed
WO-2026107134-A1 USE OF SMALL MOLECULE GLUTAMINASE INHIBITORS FOR TREATING AGE-RELATED DISORDERS LEAL THERAPEUTICS, INC. (US) 2026-05-21 WO disclosed
WO-1993001810-A1 ANALOGS OF CALICHEAMICIN η1I, METHOD OF MAKING AND USING THE SAME THE SCRIPPS RESEARCH INSTITUTE (US) 1993-02-04 WO disclosed
JP-S5862182-A 1,2,4-DITHIAZOLIDINE-3,5-DIONES, THEIR PREPARATIONS, AND FUNGICIDE COMPRISING THEM AS ACTIVE INGREDIENT SUMITOMO CHEM CO LTD 1983-04-13 JP disclosed
JP-S5846080-A 1,2,4-DITHIAZOLIDINE-3,5-DIONE COMPOUND, ITS PREPARATION, AND GERMICIDE CONTAINING SAID COMPOUND AS ACTIVE COMPONENT SUMITOMO CHEM CO LTD 1983-03-17 JP disclosed
JP-S5843966-A 1,2,4-DITHIAZOLIDENE-3,5-DIONE COMPOUND, ITS PREPARATION, AND GERMICIDE CONTAINING SAID COMPOUND AS ACTIVE COMPONENT SUMITOMO CHEM CO LTD 1983-03-14 JP disclosed
JP-S57108085-A 1,2,4-DITHIAZOLIDINE-3,5-DIONES, THEIR PREPARATIONS, AND FUNGICIDES COMPRISING THEM AS ACTIVE INGREDIENTS SUMITOMO CHEM CO LTD 1982-07-05 JP disclosed
US-3962327-A FROM N-HALOFORMYLCARBAMIC ACID THIO ESTER AND A HALOGEN BAYER AKTIENGESELLSCHAFT (DT) 1976-06-08 US disclosed